MONICA D SARANG
Allopathic & Osteopathic Physicians|Internal Medicine BURBANK, CA NPI 1770516486
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine CA Amgen Inc. All categories
General Payments — all program years on this page
$7,373.90
- Category: General Payments
- Program years: PY2018–2024
- Record count: 350
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,213.22 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,213.22 | 52 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $141.58 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $121.10 | 5 |
| Bausch Health US, LLC | $117.38 | 5 |
| Lilly USA, LLC | $113.86 | 4 |
| Acerta Pharma LLC | $104.04 | 5 |
| GlaxoSmithKline, LLC. | $75.02 | 3 |
| ABBVIE INC. | $69.39 | 3 |
| Novo Nordisk AS | $65.46 | 3 |
| Exact Sciences Corporation | $62.03 | 2 |
| Antares Pharma, Inc. | $54.92 | 2 |
| Regeneron Healthcare Solutions, Inc. | $34.97 | 1 |
| GENZYME CORPORATION | $31.18 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.16 | 2 |
| SANOFI PASTEUR INC. | $27.92 | 1 |
| Hologic Sales and Service, LLC | $26.27 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.89 | 1 |
| Verity Pharmaceuticals Inc. | $23.46 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $20.78 | 1 |
| Abbott Laboratories | $19.84 | 1 |
| PFIZER INC. | $19.54 | 1 |
| Currax Pharmaceuticals LLC | $15.63 | 1 |
| IBSA Pharma Inc. | $13.80 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.